These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. A trial of integrated buprenorphine/naloxone and HIV clinical care. Sullivan LE; Barry D; Moore BA; Chawarski MC; Tetrault JM; Pantalon MV; O'Connor PG; Schottenfeld RS; Fiellin DA Clin Infect Dis; 2006 Dec; 43 Suppl 4():S184-90. PubMed ID: 17109305 [TBL] [Abstract][Full Text] [Related]
7. Cocaine use reduction with buprenorphine (CURB): rationale, design, and methodology. Mooney LJ; Nielsen S; Saxon A; Hillhouse M; Thomas C; Hasson A; Stablein D; McCormack J; Lindblad R; Ling W Contemp Clin Trials; 2013 Mar; 34(2):196-204. PubMed ID: 23159524 [TBL] [Abstract][Full Text] [Related]
8. The impact of cocaine use on outcomes in HIV-infected patients receiving buprenorphine/naloxone. Sullivan LE; Botsko M; Cunningham CO; O'Connor PG; Hersh D; Mitty J; Lum PJ; Schottenfeld RS; Fiellin DA; J Acquir Immune Defic Syndr; 2011 Mar; 56 Suppl 1(Suppl 1):S54-61. PubMed ID: 21317595 [TBL] [Abstract][Full Text] [Related]
9. Effectiveness of Injectable Extended-Release Naltrexone vs Daily Buprenorphine-Naloxone for Opioid Dependence: A Randomized Clinical Noninferiority Trial. Tanum L; Solli KK; Latif ZE; Benth JŠ; Opheim A; Sharma-Haase K; Krajci P; Kunøe N JAMA Psychiatry; 2017 Dec; 74(12):1197-1205. PubMed ID: 29049469 [TBL] [Abstract][Full Text] [Related]
10. Medical treatments for opioid use disorder in Iran: a randomized, double-blind placebo-controlled comparison of buprenorphine/naloxone and naltrexone maintenance treatment. Mokri A; Chawarski MC; Taherinakhost H; Schottenfeld RS Addiction; 2016 May; 111(5):874-82. PubMed ID: 26639678 [TBL] [Abstract][Full Text] [Related]
11. HIV clinic-based buprenorphine plus naloxone versus referral for methadone maintenance therapy for treatment of opioid use disorder in HIV clinics in Vietnam (BRAVO): an open-label, randomised, non-inferiority trial. Korthuis PT; King C; Cook RR; Khuyen TT; Kunkel LE; Bart G; Nguyen T; Thuy DT; Bielavitz S; Nguyen DB; Tam NTM; Giang LM Lancet HIV; 2021 Feb; 8(2):e67-e76. PubMed ID: 33539760 [TBL] [Abstract][Full Text] [Related]
12. Counseling plus buprenorphine-naloxone for opioid dependence. Gorelick DA N Engl J Med; 2006 Oct; 355(16):1736; author reply 1736-7. PubMed ID: 17050900 [No Abstract] [Full Text] [Related]
13. Who benefits from additional drug counseling among prescription opioid-dependent patients receiving buprenorphine-naloxone and standard medical management? Weiss RD; Griffin ML; Potter JS; Dodd DR; Dreifuss JA; Connery HS; Carroll KM Drug Alcohol Depend; 2014 Jul; 140():118-22. PubMed ID: 24831754 [TBL] [Abstract][Full Text] [Related]
14. A randomized trial of cognitive behavioral therapy in primary care-based buprenorphine. Fiellin DA; Barry DT; Sullivan LE; Cutter CJ; Moore BA; O'Connor PG; Schottenfeld RS Am J Med; 2013 Jan; 126(1):74.e11-7. PubMed ID: 23260506 [TBL] [Abstract][Full Text] [Related]
15. Initial response as a predictor of 12-week buprenorphine-naloxone treatment response in a prescription opioid-dependent population. McDermott KA; Griffin ML; Connery HS; Hilario EY; Fiellin DA; Fitzmaurice GM; Weiss RD J Clin Psychiatry; 2015 Feb; 76(2):189-94. PubMed ID: 25562462 [TBL] [Abstract][Full Text] [Related]
16. Desipramine in opioid-dependent cocaine abusers maintained on buprenorphine vs methadone. Oliveto AH; Feingold A; Schottenfeld R; Jatlow P; Kosten TR Arch Gen Psychiatry; 1999 Sep; 56(9):812-20. PubMed ID: 12884887 [TBL] [Abstract][Full Text] [Related]
17. Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trial. Woody GE; Poole SA; Subramaniam G; Dugosh K; Bogenschutz M; Abbott P; Patkar A; Publicker M; McCain K; Potter JS; Forman R; Vetter V; McNicholas L; Blaine J; Lynch KG; Fudala P JAMA; 2008 Nov; 300(17):2003-11. PubMed ID: 18984887 [TBL] [Abstract][Full Text] [Related]
18. A randomized, double-blind evaluation of buprenorphine taper duration in primary prescription opioid abusers. Sigmon SC; Dunn KE; Saulsgiver K; Patrick ME; Badger GJ; Heil SH; Brooklyn JR; Higgins ST JAMA Psychiatry; 2013 Dec; 70(12):1347-54. PubMed ID: 24153411 [TBL] [Abstract][Full Text] [Related]
19. Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence. Schottenfeld RS; Chawarski MC; Pakes JR; Pantalon MV; Carroll KM; Kosten TR Am J Psychiatry; 2005 Feb; 162(2):340-9. PubMed ID: 15677600 [TBL] [Abstract][Full Text] [Related]
20. Behavioral counseling and abstinence-contingent take-home buprenorphine in general practitioners' offices in Malaysia: a randomized, open-label clinical trial. Schottenfeld RS; Chawarski MC; Mazlan M Addiction; 2021 Aug; 116(8):2135-2149. PubMed ID: 33404150 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]